A Multi-Component Reaction Peptide Augmenting the Anti-Aging Benefits of Non-Ablative Laser Procedure.

IF 1.8 4区 医学 Q3 DERMATOLOGY Journal of Drugs in Dermatology Pub Date : 2025-02-01 DOI:10.36849/JDD.8066
Kun Mark Qian, Michael Kaminer, I-Chien Liao, Janet Wangari-Olivero, Jyotsna Paturi, Ying Chen, Patricia Brieva, Rabije Cekovic, Charbel Bouez, Qian Zheng
{"title":"A Multi-Component Reaction Peptide Augmenting the Anti-Aging Benefits of Non-Ablative Laser Procedure.","authors":"Kun Mark Qian, Michael Kaminer, I-Chien Liao, Janet Wangari-Olivero, Jyotsna Paturi, Ying Chen, Patricia Brieva, Rabije Cekovic, Charbel Bouez, Qian Zheng","doi":"10.36849/JDD.8066","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Laser resurfacing is one of the most popular aesthetic procedures that address a wide range of skin conditions and overall skin rejuvenation. To reduce downtime and improve the clinical efficacy of the procedures, it is important to design post-procedure care routines to complement them. Towards fulfilling that consumer need, a peptide synthesized from multi-component reaction (MCP) has been developed.</p><p><strong>Aims: </strong>&nbsp;The objective of this study is to investigate the functionalities of MCP as a regenerative active that enhances the healing kinetics and anti-aging performance following non-ablative fractional laser resurfacing procedures.</p><p><strong>Methods: </strong>&nbsp;To fulfill the objective, a single-center, split-face design, double-blinded, randomized clinical study was conducted. Study participants received a full face non-ablative fractional laser procedure followed by treatment with two topical products, MCP formula or Aquaphor Healing Ointment&reg;or AHO (Beiersdorf Inc, Wilton, CT) as a standard of care topical agent. Both products were applied immediately after the laser procedure and continued two times daily for 28 days. Clinical evaluation and expert grading of healing and aging, instrument measurement of skin barrier function, optical coherence tomography and standardized digital imaging were performed.</p><p><strong>Results: </strong>&nbsp;Clinical evaluation results showed that the MCP formula promoted post-procedure skin healing at a comparable level as Aquaphor Healing Ointment&reg;. However, the MCP formula demonstrated faster kinetics and enhanced level of improvement in multiple anti-aging parameters when compared with the benchmark control. Results from this clinical study demonstrate that the use of MCP formula post non-ablative fractional laser treatment is efficacious in promoting skin healing and enhancing the anti-aging benefits provided by the procedure. J Drugs Dermatol. 2025;24(2):188-195. doi:10.36849/JDD.8066R1.</p>","PeriodicalId":15566,"journal":{"name":"Journal of Drugs in Dermatology","volume":"24 2","pages":"188-195"},"PeriodicalIF":1.8000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drugs in Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36849/JDD.8066","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Laser resurfacing is one of the most popular aesthetic procedures that address a wide range of skin conditions and overall skin rejuvenation. To reduce downtime and improve the clinical efficacy of the procedures, it is important to design post-procedure care routines to complement them. Towards fulfilling that consumer need, a peptide synthesized from multi-component reaction (MCP) has been developed.

Aims:  The objective of this study is to investigate the functionalities of MCP as a regenerative active that enhances the healing kinetics and anti-aging performance following non-ablative fractional laser resurfacing procedures.

Methods:  To fulfill the objective, a single-center, split-face design, double-blinded, randomized clinical study was conducted. Study participants received a full face non-ablative fractional laser procedure followed by treatment with two topical products, MCP formula or Aquaphor Healing Ointment®or AHO (Beiersdorf Inc, Wilton, CT) as a standard of care topical agent. Both products were applied immediately after the laser procedure and continued two times daily for 28 days. Clinical evaluation and expert grading of healing and aging, instrument measurement of skin barrier function, optical coherence tomography and standardized digital imaging were performed.

Results:  Clinical evaluation results showed that the MCP formula promoted post-procedure skin healing at a comparable level as Aquaphor Healing Ointment®. However, the MCP formula demonstrated faster kinetics and enhanced level of improvement in multiple anti-aging parameters when compared with the benchmark control. Results from this clinical study demonstrate that the use of MCP formula post non-ablative fractional laser treatment is efficacious in promoting skin healing and enhancing the anti-aging benefits provided by the procedure. J Drugs Dermatol. 2025;24(2):188-195. doi:10.36849/JDD.8066R1.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一种多组分反应肽增强非烧蚀激光手术的抗衰老益处。
背景:激光表面修复是最流行的美容程序之一,解决了广泛的皮肤状况和整体皮肤年轻化。为了减少手术时间,提高手术的临床疗效,设计手术后护理程序是很重要的。为了满足消费者的需求,一种由多组分反应合成的肽(MCP)已经被开发出来。目的:本研究的目的是研究MCP作为一种再生活性物质的功能,它可以增强非烧蚀性激光表面修复手术后的愈合动力学和抗衰老性能。方法:为达到目的,采用单中心、裂面设计、双盲、随机临床研究。研究参与者接受全脸非消融分次激光手术,随后使用两种外用产品,MCP配方或Aquaphor愈合软膏或who(拜尔斯道夫公司,威尔顿,CT)作为标准护理外用药物进行治疗。这两种产品在激光手术后立即应用,每天两次,持续28天。进行愈合和衰老的临床评价和专家评分、皮肤屏障功能的仪器测量、光学相干断层扫描和标准化数字成像。结果:临床评价结果显示,MCP配方对术后皮肤愈合的促进作用与阿夸弗愈合软膏相当。然而,与基准对照相比,MCP配方表现出更快的动力学和更强的抗衰老参数改善水平。本临床研究结果表明,在非烧蚀分次激光治疗后使用MCP配方可有效促进皮肤愈合并增强该过程提供的抗衰老益处。皮肤医学杂志,2025;24(2):188-195。doi: 10.36849 / JDD.8066R1。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.20
自引率
13.30%
发文量
289
审稿时长
3-6 weeks
期刊介绍: The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology. We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality. Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.
期刊最新文献
Impact of TNF-α and IL-17 Biologics on Cardiometabolic Outcomes in Hidradenitis Suppurativa: Retrospective Cohort Study. Management of Nail Toxicities From Fibroblast Growth Factor Receptor Inhibitors. Persistent Alopecic Patches Following Dutasteride Mesotherapy for Female Androgenetic Alopecia: A Case Series. Patient Perspectives and Attitudes Toward the Diagnostic Process for Central Centrifugal Cicatricial Alopecia. Pseudo-Psoriatic Nail Dystrophy Associated With Cosmetic Nail Products.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1